APA način citiranja

Matsuo, H., Yoshida, K., Nakatani, K., Harata, Y., Higashitani, M., Ito, Y., . . . Adachi, S. (2020). Fusion partner–specific mutation profiles and KRAS mutations as adverse prognostic factors in MLL-rearranged AML. Blood Adv.

Čikaški stil citiranja

Matsuo, Hidemasa, et al. "Fusion Partner–specific Mutation Profiles and KRAS Mutations As Adverse Prognostic Factors in MLL-rearranged AML." Blood Adv 2020.

MLA način citiranja

Matsuo, Hidemasa, et al. "Fusion Partner–specific Mutation Profiles and KRAS Mutations As Adverse Prognostic Factors in MLL-rearranged AML." Blood Adv 2020.